Neurotrophic Keratitis Market is segmented By Treatment (Drugs, Surgical Procedures, Other Therapies...
Market Size in USD Mn
CAGR9.4%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 9.4% |
Market Concentration | High |
Major Players | RegeneRx Biopharmaceuticals, Inc., Dompé Farmaceutici S.p.A, Aldeyra Therapeutics, ReGenTree LLC, Oxurion NV and Among Others |
The neurotrophic keratitis market is estimated to be valued at USD 203.1 Mn in 2025 and is expected to reach USD 380.9 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.4% from 2025 to 2032. The neurotrophic keratitis market is witnessing significant growth owing to rising incidence of ocular disorders, growing geriatric population, and technological advancements in drug delivery methods.